Participated · Seed · Aug 2026

Multiplier builds a customized coding agent platform engineered for fundamental equity hedge funds, deploying adaptable coding agents that integrate with a fund’s internal documentation, structured financial models, and external unstructured communication streams. The platform functions as an automated investment assistant that handles information triage, generates data visualizations, and tracks portfolio exposure overnight. Multiplier claims its system enables analysts to double their stock coverage depth while working toward replacing traditional terminal subscription overhead. The company was founded by Ian McInnis, Ben Finch, and Ryan Winkler and is positioned to deepen in-person implementation with hedge fund clients through a planned headquarters relocation to Midtown East, New York City. Its recent $6M seed raise will fund engineering hires and high-performance token compute capacity to support product development and deployments.

Participated · Series A · Aug 2026

Andromeda Surgical is developing an autonomous surgery platform and is beginning clinical and commercial activity in endourology. The company is initially focusing on procedures that treat BPH, prostate cancer, bladder cancer, and kidney stones, and reports that urologists in three countries have used its platform to perform holmium laser enucleation of the prostate (HoLEP) in more than 40 patients. It has observed enucleation times as fast as 30 minutes versus a published average of about 90 minutes. The team combines surgical deeptech and healthcare expertise from organizations including Neuralink, Science Corp, Avail, and the group that launched the first autonomous truck at Starsky Robotics. Andromeda has raised $30 million to date, including a $15 million Series A, and has been cleared to launch commercially in Canada and New Zealand. The company plans to deploy its first commercial systems into hospitals in the coming months and to scale utilization while expanding into additional procedures and autonomous capabilities.

Participated · Series A · Jul 2026

Dili builds an AI-driven compliance platform tailored to the complex regulatory requirements around construction and infrastructure projects, including prevailing wage and apprenticeship rules. Its architecture uses contemporary AI models to extract structured data from unstructured documents, then applies a deterministic rules engine to avoid LLM-induced errors in final compliance decisions. The company reports the software is already deployed on about 700 projects spanning manufacturing facilities to data centers. Approximately half of those projects use Dili as an in-house tool while the other half outsource compliance to Dili under a contractor model. Dili’s leadership expects the market to shift toward in-house software adoption over time as AI automates professional services workflows. The company emphasizes reliability due to the high financial risks of non-compliance, noting violations can result in millions of dollars in fines.

Participated · Seed · Jul 2026

Klaimee offers insurance-backed performance warranties designed for autonomous AI agents. The company is backed by Y Combinator (P26). Its core product is positioned at the intersection of insurance and AI, targeting risk transfer around agent performance. Financially, Klaimee has just completed a $5.5 million seed round. The article does not report revenue, user metrics, or detailed future product roadmaps.

Participated · Seed · Jul 2026

Public information about Ossprey in the cited article is limited to its fundraising announcement. The LinkedIn post reports only that Ossprey raised $2.65 million in a pre-seed round and provides no description of the company’s product, services, market, founding year, location, or operating metrics. The article does not disclose leadership, revenue, user counts, or specific plans for the newly raised capital. No additional company details were included in the source article.